Global Technologies, Ltd. (GTLL)
Oxford Ledge is still expanding full research coverage of GTLL. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Global Technologies operates health-sector subsidiaries providing pharmaceutical procurement and business advisory services.
SEC filings
- 8-K 4.01; Financial statements and exhibits 2026-06-16
- 8-K Entry into material agreement; 3.02; Departure/election of directors or officers; Amendments to articles or bylaws; Regulation FD disclosure; Financial statements and exhibits 2026-06-09
- 10-Q Quarterly financial report (unaudited) 2026-06-03
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-03-26
- 10-Q/A Amended quarterly report 2026-03-23
Source: SEC EDGAR.
Annual results
5 years of annual figures for GTLL, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2025 | — | -$342,681 | $0.00 |
| 2024 | — | $265,421 | $0.00 |
| 2023 | $17,000 | -$1.0M | $0.00 |
| 2022 | $124,506 | -$1.3M | $0.00 |
| 2021 | $15,000 | -$4.2M | — |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
Insider activity
5 recent insider (SEC Form 4) filings on record for GTLL. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open GTLL in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.